Aging and hypertension

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 11, 2010, Pages 1531-1539

  Fukutomi, Motoki ^a   Kario, Kazuomi ^b  

^a Yamaguchi Grand Medical Center   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

aging; arterial structure; circadian rhythm; hypertension; morning hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT;

AGED; AGING; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTERY COMPLIANCE; ARTERY INTIMA; ARTERY RESISTANCE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; BLOOD VISCOSITY; DIURETIC THERAPY; ENVIRONMENTAL FACTOR; ESSENTIAL HYPERTENSION; GLOMERULOSCLEROSIS; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY MASS; KIDNEY PERFUSION; KIDNEY SIZE; MENTAL STRESS; MORNING HYPERTENSION; NOCTURNAL HYPERTENSION; NONHUMAN; ORTHOSTATIC HYPERTENSION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; RENAL ARTERY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM EXCRETION; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; WHITE COAT HYPERTENSION;

AGED; AGED, 80 AND OVER; AGING; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 78649347073     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.78     Document Type: Review

References (77)

1. From the Centers for Disease Control and Prevention. Public health and aging: trends in aging-United States and worldwide. JAMA 289(11), 1371-1373 (2003).
2. Franklin SS, Gustin WT, Wong ND et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 96(1), 308-315 (1997).
3. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a 'set up' for vascular disease. Circulation 107(1), 139-146 (2003). (Pubitemid 36070946)
4. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation 107(3), 490-497 (2003).
5. Liao D, Arnett DK, Tyroler HA et al. Arterial stiffness and the development of hypertension. The ARIC study. Hypertension 34(2), 201-206 (1999).
6. Egashira K, Inou T, Hirooka Y et al. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 88(1), 77-81 (1993).
7. Taddei S, Virdis A, Mattei P et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 91(7), 1981-1987 (1995).
8. Nilsson PM, Boutouyrie P, Laurent S. Vascular aging. A tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension 54(1), 3-10 (2009).
9. Tomiyama H, Matsumoto C, Yamada J et al. Predictors of progression from prehypertension to hypertension in Japanese men. Am. J. Hypertens. 22(6), 630-636 (2009).
10. James MA, Tullett J, Hemsley AG, Shore AC. Effects of aging and hypertension on the microcirculation. Hypertension 47(5), 968-974 (2006).
11. Guyton AC, Coleman TG, Cowley AV Jr, Scheel KW, Manning RD Jr, Norman RA Jr. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am. J. Med. 52(5), 584-594 (1972).
12. Guidi E, Menghetti D, Milani S, Montagnino G, Palazzi P, Bianchi G. Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families. J. Am. Soc. Nephrol. 7(8), 1131-1138 (1996).
13. Martin JE, Sheaff MT. Renal ageing. J. Pathol. 211(2), 198-205 (2007).
14. Fukuda M, Munemura M, Usami T et al. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int. 65(2), 621-625 (2004).
15. Goto N, Uchida K, Morozumi K et al. Circadian blood pressure rhythm is disturbed by nephrectomy. Hypertens. Res. 28(4), 301-306 (2005).
16. Fukuda M, Goto N, Kimura G. Hypothesis on renal mechanism of non-dipper pattern of circadian blood pressure rhythm. Med. Hypotheses 67(4), 802-806 (2006).
17. Takeda K, Bunag RD. Sympathetic hyperactivity during hypothalamic stimulation in spontaneously hypertensive rats. J. Clin. Invest. 62(3), 642-648 (1978).
18. Cassis LA, Stitzel RE, Head RJ. Hypernoradrenergic innervation of the caudal artery of the spontaneously hypertensive rat: an infuence upon neuroeffector mechanisms. J. Pharmacol. Exp. Ther. 234(3), 792-803 (1985).
19. Schlaich MP, Lambert E, Kaye DM et al. Sympathetic augmentation in hypertension: role of nerve fring, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43(2), 169-175 (2004).
20. Seals DR, Esler MD. Human ageing and the sympathoadrenal system. J. Physiol. 528(Pt 3), 407-417 (2000).
21. Hart EC, Joyner MJ, Wallin BG et al. Age-related differences in the sympathetic-hemodynamic balance in men. Hypertension 54(1), 127-133 (2009).
22. Sundlof G, Wallin BG. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J. Physiol. 274, 621-637 (1978). (Pubitemid 8284570)
23. Narkiewicz K, Phillips BG, Kato M, Hering D, Bieniaszewski L, Somers VK. Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 45(4), 522-525 (2005).
24. Kario K, Eguchi K, Hoshide S et al. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: orthostatic hypertension as a new cardiovascular risk factor. J. Am. Coll. Cardiol. 40(1), 133-141 (2002).
25. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N. Engl. J. Med. 328(5), 303-307 (1993).
26. Narkiewicz K, Winnicki M, Schroeder K et al. Relationship between muscle sympathetic nerve activity and diurnal blood pressure profle. Hypertension 39(1), 168-172 (2002).
27. Grassi G, Seravalle G, Quarti-Trevano F et al. Adrenergic, metabolic, and refex abnormalities in reverse and extreme dipper hypertensives. Hypertension 52(5), 925-931 (2008).
28. Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J. Hypertens. 26(5), 831-843 (2008).
29. Zozaya JL, Viloria MP, Castro A. The effect of age on the renin-angiotensin-aldosterone systems and other physiological variables in normal subjects. Res. Commun. Chem. Pathol. Pharmacol. 42(3), 463-470 (1983).
30. Anderson S. Ageing and the renin-angiotensin system. Nephrol. Dial. Transplant. 12(6), 1093-1094 (1997).
31. Bader M, Ganten D. Update on tissue renin-angiotensin systems. J. Mol. Med. 86(6), 615-621 (2008).
32. Kasper SO, Carter CS, Ferrario CM et al. Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin systems. Physiol. Genomics 23(3), 311-317 (2005).
33. Wang M, Zhang J, Spinetti G et al. Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats. Am. J. Pathol. 167(5), 1429-1442 (2005).
34. Wang M, Takagi G, Asai K et al. Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension 41(6), 1308-1316 (2003).
35. Wang M, Zhang J, Jiang LQ et al. Proinfammatory profle within the grossly normal aged human aortic wall. Hypertension 50(1), 219-227 (2007).
36. Julius S, Nesbitt SD, Egan BM et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N. Engl. J. Med. 354(16), 1685-1697 (2006).
37. Oliver WJ, Cohen EL, Neel JV. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a 'no-salt' culture. Circulation 52(1), 146-151 (1975).
38. Timio M, Lippi G, Venanzi S et al. Blood pressure trend and cardiovascular events in nuns in a secluded order: a 30-year follow-up study. Blood Press. 6(2), 81-87 (1997). (Pubitemid 27162838)
39. Sparrenberger F, Cichelero F T, Ascoli AM et al. Does psychosocial stress cause hypertension? A systematic review of observational studies. J. Hum. Hypertens. 23(1), 12-19 (2009).
40. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: ana lysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 37(3), 869-874 (2001).
41. Staessen JA, Fagard R, Thijs L et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 350(9080), 757-764 (1997).
42. Staessen JA, Gasowski J, Wang JG et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-ana lysis of outcome trials. Lancet 355(9207), 865-872 (2000).
43. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 265(24), 3255-3264 (1991).
44. Liu L, Wang JG, Gong L, Liu G, Staessen JA. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J. Hypertens. 16(12 Pt 1), 1823-1829 (1998).
45. Kjeldsen SE, Dahlof B, Devereux RB et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 288(12), 1491-1498 (2002).
46. Dolan E, Stanton A, Atkins N et al. Determinants of white-coat hypertension. Blood Press. Monit. 9(6), 307-309 (2004).
47. Manios ED, Koroboki EA, Tsivgoulis GK et al. Factors infuencing white-coat effect. Am. J. Hypertens. 21(2), 153-158 (2008).
48. Kario K, Eguchi K, Nakagawa Y, Motai K, Shimada K. Relationship between extreme dippers and orthostatic hypertension in elderly hypertensive patients. Hypertension 31(1), 77-82 (1998).
49. Kario K, Ishikawa J, Pickering TG et al. Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens. Res. 29(8), 581-587 (2006).
50. Ugajin T, Hozawa A, Ohkubo T et al. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. Arch. Intern. Med. 165(13), 1541-1546 (2005).
51. Mancia G, Bombelli M, Facchetti R et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension 54(2), 226-232 (2009).
52. Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J. Hum. Hypertens. 17(12), 811-817 (2003).
53. Verdecchia P, Reboldi GP, Angeli F et al. Short-and long-term incidence of stroke in white-coat hypertension. Hypertension 45(2), 203-208 (2005).
54. De Simone G, Schillaci G, Chinali M, Angeli F, Reboldi GP, Verdecchia P. Estimate of white-coat effect and arterial stiffness. J. Hypertens. 25(4), 827-831 (2007).
55. Longo D, Zaetta V, Perkovic D et al. Impaired arterial elasticity in young patients with white-coat hypertension. Blood Press. Monit. 11(5), 243-249 (2006).
56. Nakashima T, Yamano S, Sasaki R et al. White-coat hypertension contributes to the presence of carotid arteriosclerosis. Hypertens. Res. 27(10), 739-745 (2004).
57. Staessen JA, Bieniaszewski L, O'Brien E et al. Nocturnal blood pressure fall on ambulatory monitoring in a large international database. The 'Ad Hoc' Working Group. Hypertension 29(1 Pt 1), 30-39 (1997).
58. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 38(4), 852-857 (2001).
59. Silva AP, Moreira C, Bicho M, Paiva T, Clara JG. Nocturnal sleep quality and circadian blood pressure variation. Rev. Port. Cardiol. 19(10), 991-1005 (2000).
60. Scuteri A, Spalletta G, Cangelosi M et al. Decreased nocturnal systolic blood pressure fall in older subjects with depression. Aging Clin. Exp. Res. 21(4-5), 292-297 (2009).
61. Guo H, Tabara Y, Igase M et al. Abnormal nocturnal blood pressure profle is associated with mild cognitive impairment in the elderly: the J-SHIPP study. Hypertens. Res. 33(1), 32-36 (2010).
62. Kimura G, Sanai T, Saito F, Uzu T. Renal determinants for sodium sensitivity of blood pressure. Hypertension 28(6), 1102-1103 (1996). (Pubitemid 26415833)
63. Verdecchia P, Schillaci G, Guerrieri M et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81(2), 528-536 (1990).
64. Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J. Hypertens. 10(8), 875-878 (1992).
65. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am. J. Hypertens. 7(1), 23-29 (1994).
66. Asayama K, Ohkubo T, Kikuya M et al. Prediction of stroke by home 'morning' versus 'evening' blood pressure values: the Ohasama study. Hypertension 48(4), 737-743 (2006).
67. Kario K, Pickering TG, Hoshide S et al. Morning blood pressure surge and hypertensive cerebrovascular disease: role of the a adrenergic sympathetic nervous system. Am. J. Hypertens. 17(8), 668-675 (2004).
68. Kario K, Pickering TG, Umeda Y et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 107(10), 1401-1406 (2003).
69. Yano Y, Hoshide S, Inokuchi T, Kanemaru Y, Shimada K, Kario K. Association between morning blood pressure surge and cardiovascular remodeling in treated elderly hypertensive subjects. Am. J. Hypertens. 22(11), 1177-1182 (2009).
70. Rizzoni D, Porteri E, Platto C et al. Morning rise of blood pressure and subcutaneous small resistance artery structure. J. Hypertens. 25(8), 1698-1703 (2007).
71. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am. J. Hypertens. 17(12 Pt 1), 1192-1200 (2004).
72. Wong TY, Klein R, Sharrett AR et al. Retinal arteriolar diameter and risk for hypertension. Ann. Intern. Med. 140(4), 248-255 (2004).
73. Kario K. Preceding linkage between a morning surge in blood pressure and small artery remodeling: an indicator of prehypertension? J. Hypertens. 25(8), 1573-1575 (2007).
74. Wu JS, Yang YC, Lu FH, Wu CH, Chang CJ. Population-based study on the prevalence and correlates of orthostatic hypotension/hypertension and orthostatic dizziness. Hypertens. Res. 31(5), 897-904 (2008).
75. Hoshide S, Matsui Y, Shibasaki S et al. Orthostatic hypertension detected by self-measured home blood pressure monitoring: a new cardiovascular risk factor for elderly hypertensives. Hypertens. Res. 31(8), 1509-1516 (2008).
76. Eguchi K, Kario K, Hoshide S et al. Greater change of orthostatic blood pressure is related to silent cerebral infarct and cardiac overload in hypertensive subjects. Hypertens. Res. 27(4), 235-241 (2004).
77. Thomas RJ, Liu K, Jacobs DR Jr, Bild DE, Kiefe CI, Hulley SB. Positional change in blood pressure and 8-year risk of hypertension: the CARDIA Study. Mayo Clin. Proc. 78(8), 951-958 (2003).